First Time Loading...

Eyenovia Inc
NASDAQ:EYEN

Watchlist Manager
Eyenovia Inc Logo
Eyenovia Inc
NASDAQ:EYEN
Watchlist
Price: 0.7713 USD -4.14% Market Closed
Updated: May 12, 2024

P/E
Price to Earnings

-1.4
Current
-5.7
Median
23.4
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-1.4
=
Market Cap
39.3m
/
Net Income
-27.3m
All Countries
Close
Market Cap P/E
US
Eyenovia Inc
NASDAQ:EYEN
39.3m USD -1.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY -5 347 888.9
US
Eli Lilly and Co
NYSE:LLY
722.3B USD 117.7
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 44.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP -15 783.5
US
Johnson & Johnson
NYSE:JNJ
360.8B USD 9.4
US
Merck & Co Inc
NYSE:MRK
329.4B USD 142.8
UK
AstraZeneca PLC
LSE:AZN
191.8B GBP 37.9
CH
Novartis AG
SIX:NOVN
180.6B CHF 11.4
CH
Roche Holding AG
SIX:ROG
179.5B CHF 15.6
US
Pfizer Inc
NYSE:PFE
158.1B USD -511.8
Earnings Growth
US
Eyenovia Inc
NASDAQ:EYEN
Average P/E: 54.1
Negative Multiple: -1.4
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
117.7
346%
DK
Novo Nordisk A/S
CSE:NOVO B
44.1
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.4
-20%
US
Merck & Co Inc
NYSE:MRK
142.8
7 454%
UK
AstraZeneca PLC
LSE:AZN
37.9
168%
CH
Novartis AG
SIX:NOVN
11.4
15%
CH
Roche Holding AG
SIX:ROG
15.6
26%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -511.8
680%

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-1.1
2-Years Forward
P/E
-1.1
3-Years Forward
P/E
-1.5

See Also

Discover More